4-WEEK OPEN-LABEL CONTROLLED RANDOMIZED COMPARATIVE STUDY OF THE INJECTABLE AND TABLETTED FORMULATIONS OF METHOTREXATE IN RHEUMATOID ARTHRITIS

Objective: to estimate the advantages and disadvantages of using the injectable formulation of methotrexate (MT) (Methoject (MTJ)) in rheumatoid arthritis (RA) in clinical practice. Subjects and methods. A 24-week open-label controlled randomized comparative study evaluated the therapeutic and side...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yu. V. Muravyev, L. N. Denisov, A. V. Alekseyeva, N. V. Muravyeva, E. L. Shakhramanova, K. A. Kasumova, D. A. Gukasyan, I. S. Dydykina, V. V. Lebedeva, E. L. Nasonov
Médium: Artigo
Jazyk:Russo
Vydáno: IMA-PRESS LLC 2011-06-01
Edice:Научно-практическая ревматология
Témata:
rheumatoid arthritis
methotrexate
methoject
injectable formulation
tabletted formulation
adverse reactions
On-line přístup:https://rsp.mediar-press.net/rsp/article/view/1294
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky